Clearside Biomedical

$1.61 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Clearside Biomedical

Clearside Biomedical, Inc. operates as a biopharmaceutical company. The Company focuses on developing drug therapies to treat blinding diseases of the eye affecting the retina and choroid. Clearside Biomedical serves patients worldwide.

Stock Analysis

last close $1.61
1-mo return -6.9%
3-mo return 10.3%
avg daily vol. 120.03T
52-week high 7.73
52-week low 1.26
market cap. $100M
forward pe -
annual div. -
roe 0.34%
ltg forecast -
dividend yield -
annual rev. $30M
inst own. 35.4%
baraka

Subscribe now for daily local and international financial news

Subscribe